Patents, Compulsory Licensing and Business Strategy
This article explores compulsory licensing in patents under Indian law, focusing on its impact on business strategies and public interest. Through case studies and legal analysis, the article…
Patents
1,328 articles
Happy Eid al-Adha – Biryani Patents
This post examines innovative biryani patents and Eid al-Adha culinary traditions, with a focus on food-related intellectual property. It also addresses Indian GI protection for iconic dishes like…
Letter to the PM against Software patenting
A collective letter to the Prime Minister raises critical issues regarding the 2015 software patenting guidelines, citing potential harm to innovation and conflicts with Indian law. The post…
Gilead, IPA, Natco & The Bells of Harmony
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access…
Idols, Patents and Ganesha- Happy Vinayaka Chavithi!
The post explores how Ganesha idols intersect with patent law and eco-friendly innovations during Ganesh Chaturthi. It highlights inventive methods of idol making and their legal implications in…
TiVo and Patent Infringement: Suit Filed Against Samsung
TiVo has sued Samsung for allegedly infringing four of its multimedia technology patents, targeting both set-top boxes and mobile devices. This litigation highlights TiVo’s ongoing strategy to protect…
Ericsson has a (i)Ball at the Court
The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found…
Tequila’s Indian Cousin: Patent Filed for Agave albomarginata Spirit
An Indian food scientist has patented a process to produce tequila-like alcohol from Agave albomarginata, a plant native to the Rayalseema region. The innovation uses the plant’s high-starch…
Pfizer Patent on Known Substance: A Section 3(d) Analysis
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
Pfizer falls prey to Section 3(d)
This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence…